Deals & Transactions

Story

FusionIQ partners with YieldX to access fixed income and enhanced cash management solutions

FusionIQ partners with YieldX to access fixed income and enhanced cash management solutions

FusionIQ, an investment research and technology provider, has unlocked access to over one million fixed income investment products for its clients through YieldX’s InPaas API. The InPaaS API is a portfolio construction tool that optimises fixed income ETFs and closed-end funds for a desired income or yield target with the lowest risk and expense ratio.  

ACQUISITIONS

Amundi to become European ETF leader with Lyxor acquisition

Amundi to become European ETF leader with Lyxor acquisition

Amundi is to buy Lyxor’s ETF and actively managed alternative platform from Société Générale for a total cash consideration of EUR825 million, or EUR755 million excluding excess capital, in a move that will result in Amundi becoming the European leader in ETFs with EUR142 billion in assets and a 14 per cent market share in Europe. 

Story

Medical Cannabis sector comes of age with USD7.2bn acquisition of GW Pharmaceuticals, says CBDX

Medical Cannabis sector comes of age with USD7.2bn acquisition of GW Pharmaceuticals, says CBDX

The decision by traditional pharma company JAZZ Pharmaceuticals to purchase GW Pharmaceuticals, the company behind the first FDA approved drug derived from cannabis, is a notable turning point for the medical and wellness cannabis market, according to the Medical Cannabis and Wellness UCITS ETF (CBDX).